Baaritaanka hore ee kansarka beerka, gaar ahaan kuwa sidaha cagaarshowga B

La qaybso Post this

Qof kastaa wuu ogyahay in kansarka sanbabada, kansarka caloosha, kansarka mindhicirka, iyo kansarka naasuhu ay yihiin kuwo fudud oo lagu baaro baaritaanka jireed, sidaas darteed bukaannada kansarka ee la ogaado goor hore waxay leeyihiin saadaal wanaagsan oo muddada badbaadadooda aad ayey u dheereysaa.

Si kastaba ha ahaatee, kansarka beerka, oo ah kansar kale oo halis ah oo nafta halis gelinaya kaas oo xisaabiya in ka badan 55% kansarrada adduunka ee Shiinaha, way adagtahay in hore loo ogaado. Bukaanjiifka badankooda waa la ogaadaa goor dambe waxayna lumiyaan fursadda qaliinka. Inkasta oo daawaynta kale ay kala duwan yihiin, way adag tahay in la ilaaliyo badbaadada muddada dheer. Baaritaanka hore ee kansarka beerka waxay had iyo jeer ahayd dhibaato adag adduunka burooyinka.

Markan, guusha saynisyahannada Shiinaha ayaa si gaar ah u mudan sharafteena!

12-kii Maarso, Talaabada Akademiyada Sayniska Mareykanka (PNAS) ayaa siidaayay DNA-da aan unugga lahayn (cfDNA) iyo calaamadaha borotiinka oo ay dhammaystireen Xarunta Kansarka Qaranka, Cisbitaalka Kansarka ee Akadeemiyada Sayniska Caafimaadka Shiinaha iyo Beijing Panshengzi Gene Technology Co. ., Ltd. Natiijooyinka baaritaanka hore ee kansarka beerka ee kooxda mustaqbalka ee sidayaasha HBV.

Daraasadu waxay adeegsatay habka dheecaanka-qaadista dareeraha ah ee beddelka hidda-wadaha cfDNA oo ay weheliso calaamado borotiin ah oo ay si madax-bannaan u sameeyeen saynisyahano Shiinees ah—screen HCC. Xaqiijinta bukaan-socodka adag ka dib, natiijooyinka cilmi-baarista waxaa la filayaa in loo isticmaalo baaritaanka hore ee kansarka beerka.

Daraasaddan, kansarka beerka hore ee ka yar 3 cm ayaa la heli karaa. Cilmi-baadhayaashu waxay heleen muunadaha dhiigga ee wareegga DNA-da ee aan unugga lahayn iyo calaamadaha borotiinka, waxayna ku baareen 331 sidayaal HBV natiijooyin alfa-fetoprotein iyo B-ultrasound caadi ah.

Natiijooyinka 24 xaaladood ayaa la ogaaday (laga yaabo inay qabaan kansarka beerka), iyo dabagalka 6 ilaa 8 bilood, 4 xaaladood ayaa la ogaaday inay qabaan kansarka beerka. Bukaannada 307 ee soo haray ayaa taban mana jirin wax kansar beerka ah oo la helay intii lagu jiray muddada dabagalka. Gaar 100% dareenka, 94% gaar ah iyo 17% qiimaha saadaasha togan.

Beerka heerka hore kansarka waxaa lagu ogaan karaa dhiig tijaabinta sidayaal HBV asymptomatic ah. Farsamadan waxay gaari kartaa ogaanshaha saxda ah ee isbeddellada caadiga ah ee kansarka beerka sida isbeddellada dhibcaha cfDNA, isbeddellada tirtirka gelinta, iyo is-dhexgalka fayraska HBV. Waqtigan xaadirka ah, habka cilmi-baarista ayaa la sii wanaajiyay, dareenka ayaa deggan in ka badan 93%, gaar ahaanna waxaa lagu kordhin karaa in ka badan 98%.

Si kastaba ha ahaatee, wakhtigan xaadirka ah, tignoolajiyadani waxay weli ku jirtaa marxaladda cilmi-baarista, oo aan weli si rasmi ah loo ansixin baaritaanka bukaan-socodka ee baaritaanka kansarka beerka ee hore. Si kastaba ha ahaatee, dadka khatarta sare leh ama u baahan baaritaanka kansarka hore waxay dooran karaan inay aadaan isbitaal caadi ah ama xarun baaritaan caafimaad si loogu baaro caafimaadka kansarka hore!

Waqtigan xaadirka ah, dad badan oo Shiinaha ku nool ayaa jecel inay u safraan oo wax ka iibsadaan Japan. Jid ahaan, buuxi baaritaan caafimaad oo dhammaystiran, oo ay ku jiraan baaritaanka hore ee kansarrada kala duwan, oo naftaada xasillooni marka aad ciyaareyso, si aad u hubiso jir caafimaad qaba.

Ku soo Dhawo Wargeyskayaga

Hel wax cusub oo waligaa ha ka maqnaan blog ka Cancerfax

Inbadan Oo La Baadho

Lutetium Lu 177 dotatate waxa ansixisay USFDA bukaanada carruurta 12 sano iyo ka weyn ee GEP-NETS
Kansarka

Lutetium Lu 177 dotatate waxa ansixisay USFDA bukaanada carruurta 12 sano iyo ka weyn ee GEP-NETS

Lutetium Lu 177 dotatate, oo ah daawayn hor leh, ayaa dhawaan ogolaansho ka heshay Maamulka Cunnada iyo Dawooyinka ee Maraykanka (FDA) ee bukaanada carruurta, taas oo calaamad u ah guul muhiim ah oo ku saabsan kansarka carruurta. Oggolaanshahani waxa uu u taagan yahay iftiin rajo u ah carruurta la dagaallamaysa burooyinka neuroendocrine (NETs), oo ah nooc naadir ah laakiin adag oo kansar ah kaas oo inta badan caddeeya u adkaysiga daaweynta caadiga ah.

Nogapendekin alfa inbakicept-pmln waxa u ansixisay USFDA kansarka kaadiheysta ee aan muruqa ahayn ee aan ka jawaabin BCG
Kansarka kaadiheysta

Nogapendekin alfa inbakicept-pmln waxa u ansixisay USFDA kansarka kaadiheysta ee aan muruqa ahayn ee aan ka jawaabin BCG

"Nogapendekin Alfa Inbakicept-PMLN, immunotherapy novel, waxay muujinaysaa ballanqaad daawaynta kansarka kaadiheysta marka lagu daro daawaynta BCG. Habkan cusubi waxa uu bartilmaameedsanayaa calaamado gaar ah oo kansar ah iyada oo la xoojinayo jawaabta habka difaaca jidhka, iyada oo kor u qaadeysa waxtarka daaweynta dhaqameed sida BCG. Tijaabooyin caafimaad ayaa muujinaya natiijooyin dhiirigelin leh, oo muujinaya natiijooyinka bukaan-socodka oo soo hagaagay iyo horumarka suurtagalka ah ee maareynta kansarka kaadiheysta. Is-waafajinta ka dhexeeya Nogapendekin Alfa Inbakicept-PMLN iyo BCG waxay ku bishaaraynaysaa waa cusub oo daawaynta kansarka kaadiheysta."

Ma u baahan tahay caawimaad? Kooxdayadu waxay diyaar u yihiin inay ku caawiyaan.

Waxaan u rajeynaynaa caafimaad deg-deg ah mid aad jeceshahay iyo mid kuu dhow.

Bilow sheekada
Waxaan nahay Online! Nala hadal!
Sawir koodka
Hello,

Ku soo dhawoow CancerFax!

CancerFax waa madal horudhac ah oo u heellan in lagu xidho shakhsiyaadka wajahaya kansarka heerka sare ee daawaynta unugyada sida CAR T-Cell therapy, daawaynta TIL, iyo tijaabooyinka caafimaad ee adduunka oo dhan.

Nala soo socodsii waxaan kuu qaban karno.

1) Daaweynta kansarka ee dibadda?
2) CAR T-Cell therapy
3) Tallaalka kansarka
4) La-talinta fiidiyowga ee khadka tooska ah
5) daawaynta Proton